title: Using aripiprazole to attenuate paliperidone-induced hyperprolactinemia.
authors.forename: Fábio Lopes
authors.initials: FL
authors.lastname: Rocha
authors.forename: Cláudia
authors.initials: C
authors.lastname: Hara
authors.forename: Melissa Guarieiro
authors.initials: MG
authors.lastname: Ramos
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D000068180:Aripiprazole; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced*; D007555:Isoxazoles / Q000009:adverse effects*; D000068882:Paliperidone Palmitate; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects*; D015363:Quinolones / Q000627:therapeutic use*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D007555:Isoxazoles; D010879:Piperazines; D011743:Pyrimidines; D015363:Quinolones; D000068180:Aripiprazole; D000068882:Paliperidone Palmitate